Literature DB >> 16438749

Venous thromboembolism prevention in surgery and obstetrics: clinical practice guidelines.

C M Samama1, P Albaladejo, D Benhamou, M Bertin-Maghit, N Bruder, J D Doublet, S Laversin, S Leclerc, E Marret, P Mismetti, E Samain, A Steib.   

Abstract

BACKGROUND AND
OBJECTIVE: To produce up-to-date clinical practice guidelines on the prevention of venous thromboembolism in surgery and obstetrics.
METHODS: A Steering Committee defined the scope of the topic, the questions to be answered, and the assessment criteria. Eight multidisciplinary working groups (total of 70 experts) performed a critical appraisal of the literature in the following disciplines: pharmacology of antithrombotic agents, orthopaedics; general surgery (gastrointestinal (GI) and varicose vein surgery); urology; gynaecology and obstetrics; thoracic, cardiac and vascular surgery; surgery of the head, neck and spine; and surgery of burns patients. The resultant reports and guidelines were submitted for comment and completion of the Appraisal of Guidelines Research & Evaluation questionnaire to a total of 150 peer reviewers, before producing definite guidelines.
RESULTS: The report answers the following questions for each type of surgery: (i) What is the venous thromboembolism incidence according to clinical and/or paraclinical criteria in the absence of prophylaxis? (with stratification of venous thromboembolism risk into low, moderate and high categories); (ii) What is the efficacy and safety of the prophylactic measures used? (iii) When should prophylaxis be introduced and how long should it last? (iv) Does ambulatory surgery affect efficacy and safety of prophylaxis?
CONCLUSIONS: Apart from answering the above questions, the guidelines provide a summary table for each discipline. This table stratifies types of surgery into the three risk categories, specifies the recommended prophylaxis for venous thromboembolism (pharmacological and/or mechanical) and grades each recommendation. In addition, whenever appropriate, the recommended prophylaxis is adjusted to low- and high-risk patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16438749     DOI: 10.1017/S0265021505002164

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  10 in total

1.  Slow femoral venous flow and venous thromboembolism following inguinal hernioplasty in patients without or with low molecular weight heparin prophylaxis.

Authors:  F S Lozano; J Sánchez-Fernández; J R González-Porras; J García-Alovio; J A Santos; R Mateos; I Alberca
Journal:  Hernia       Date:  2015-02-08       Impact factor: 4.739

Review 2.  Safety in the operating theatre--a transition to systems-based care.

Authors:  Thomas G Weiser; Michael P Porter; Ronald V Maier
Journal:  Nat Rev Urol       Date:  2013-02-19       Impact factor: 14.432

Review 3.  Topical issues in venous thromboembolism.

Authors:  José Ignacio Abad Rico; Juan Vicente Llau Pitarch; José Antonio Páramo Fernández
Journal:  Drugs       Date:  2010-12-14       Impact factor: 9.546

4.  Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks?

Authors:  Srinevas K Reddy; Ryan S Turley; Andrew S Barbas; Jennifer L Steel; Allan Tsung; J Wallis Marsh; Bryan M Clary; David A Geller
Journal:  J Gastrointest Surg       Date:  2011-06-21       Impact factor: 3.452

5.  Venous thromboembolism after hepatic resection: analysis of 5,706 patients.

Authors:  Ryan S Turley; Srinevas K Reddy; Cynthia K Shortell; Bryan M Clary; John E Scarborough
Journal:  J Gastrointest Surg       Date:  2012-06-30       Impact factor: 3.452

6.  Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations.

Authors:  Debraj Mukherjee; Anne O Lidor; Kathryn M Chu; Susan L Gearhart; Elliott R Haut; David C Chang
Journal:  J Gastrointest Surg       Date:  2008-07-31       Impact factor: 3.452

Review 7.  Thromboprophylaxis in elderly patients undergoing major orthopaedic surgery.

Authors:  Clifford W Colwell; Mary E Hardwick
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

8.  Quality appraisal of clinical guidelines for venous thromboembolism prophylaxis in patients undergoing hip and knee arthroplasty: a systematic review.

Authors:  Yu Wang; Li-Yun Zhu; Hai-Bo Deng; Xu Yang; Lei Wang; Yuan Xu; Xiao-Jie Wang; Dong Pang; Jian-Hua Sun; Jing Cao; Ge Liu; Ying Liu; Yu-Fen Ma; Xin-Juan Wu
Journal:  BMJ Open       Date:  2020-12-10       Impact factor: 2.692

9.  28 day post-operative persisted hypercoagulability after surgery for benign diseases: a prospective cohort study.

Authors:  Jan Ulrych; Tomas Kvasnicka; Vladimir Fryba; Martin Komarc; Ivana Malikova; Filip Burget; Radka Brzezkova; Jan Kvasnicka; Zdenek Krska; Jan Kvasnicka
Journal:  BMC Surg       Date:  2016-04-06       Impact factor: 2.102

10.  Donor Selection and Prophylactic Strategy for Venous Thromboembolic Events in Living Donors of Liver Transplantation Based on Results of Thrombophilia Screening Tests.

Authors:  Hideya Kamei; Yasuharu Onishi; Nobuhiko Kurata; Masatoshi Ishigami; Yasuhiro Ogura
Journal:  Ann Transplant       Date:  2017-07-04       Impact factor: 1.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.